Regulations.gov document
Chronic Hepatitis C Virus Infection: Developing Direct-Acting Antiviral Drugs for…
Notice · FDA-2013-D-1170 · posted Jun 27, 2016
Key facts
| Document ID | FDA-2013-D-1170-0009 |
|---|---|
| Title | Chronic Hepatitis C Virus Infection: Developing Direct-Acting Antiviral Drugs for Treatment; Draft Guidance for Industry; Extension of the Comment Period |
| Document type | Notice |
| Subtype | Extension of Comment Period |
| Agency | FDA |
| Docket | FDA-2013-D-1170 |
| Posted | Jun 27, 2016 |
| Federal Register citation | 81 FR 41553 |
| FR document number | 2016-15098 |
| Comment period opens | Jun 27, 2016 |
| Comments due | Jul 20, 2016 |
| Effective date | Jun 27, 2016 |
At a glance
- 1–9 Pages
- No Open for comment
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: